Due to possible side effects, Sweden has discontinued the Moderna Covid-19 vaccination Spikevax for people younger than 30 years.
According to Xinhua news agency, the Swedish Public Health Agency stated that a preliminary analysis of data from Sweden showed that the vaccine could be linked with increased risk of myocarditis and tissue inflammation around the heart (pericarditis).
These conditions were more common in males who received the second dose.
Anders Tegnell, state epidemiologist, stated that they closely monitor the situation and respond quickly to ensure that vaccines against COVID-19 remain as safe and effective as possible.
Sweden’s decision will affect 81,000 people, but Tegnell stated that those who have already received Spikevax should not panic.
Anyone who has had their Moderna’s vaccine administered recently does not need to worry. However, it is important to know the signs to watch out for. Myocarditis and Pericarditis can be characterized by fatigue, shortness of breath and irregular heartbeats, chest pain, chest pain, chest pain, chest pain, weight loss, chest pain, or pressure.
The Public Health Agency recommended that all individuals born after 1990 receive the vaccine from Pfizer/BioNTech, until new guidelines are developed.
The authority released statistics showing that 84% of the population of Sweden has received at least one vaccine dose. 77% are inoculated.